Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Xvivo Perfusion AB

Closing information (x1000 NOK)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 605,329 Less Arrow 392,830 Less Arrow 251,984
Financial expenses 46,886 More Arrow 52,681 Less Arrow 19,704
Earnings before taxes 95,753 Less Arrow 21,107 Less Arrow 6,500
EBITDA 64,932 Less Arrow 45,949 Less Arrow -7,275
Total assets 2,224,224 Less Arrow 1,639,346 Less Arrow 1,504,374
Current assets 837,174 Less Arrow 442,222 More Arrow 533,965
Current liabilities 136,241 Less Arrow 127,600 Less Arrow 101,929
Equity capital 1,970,392 Less Arrow 1,352,784 Less Arrow 1,253,599
- share capital 815 Less Arrow 721 More Arrow 735
Employees (average) 130 Less Arrow 114 Less Arrow 92

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 88.6% Less Arrow 82.5% More Arrow 83.3%
Turnover per employee 4,656 Less Arrow 3,446 Less Arrow 2,739
Profit as a percentage of turnover 15.8% Less Arrow 5.4% Less Arrow 2.6%
Return on assets (ROA) 6.4% Less Arrow 4.5% Less Arrow 1.7%
Current ratio 614.5% Less Arrow 346.6% More Arrow 523.9%
Return on equity (ROE) 4.9% Less Arrow 1.6% Less Arrow 0.5%
Change turnover 184,625 Less Arrow 148,419 Less Arrow 76,579
Change turnover % 44% More Arrow 61% Less Arrow 44%
Chg. No. of employees 16 More Arrow 22 More Arrow 29
Chg. No. of employees % 14% More Arrow 24% More Arrow 46%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.